All articles
    Industry· 16 May 2026· 8 min read

    Quantum computing in healthcare: NHS readiness and opportunities

    UK healthcare sits on three of the largest, longest lived and most sensitive datasets in the world: NHS patient records, the UK Biobank, and the Genomics England cohort. That makes it both an early beneficiary of quantum simulation and one of the most exposed sectors to the harvest now, decrypt later threat.

    Where quantum simulation helps medicine

    Quantum computers natively simulate quantum systems. The clearest near term applications are in computational chemistry: modelling small molecule drug candidates, understanding protein and ligand binding, and accelerating catalysis design for vaccine manufacturing.

    AstraZeneca, GSK and several UK biotechs are already running pilots with Quantinuum and IBM. The work is genuinely scientific rather than marketing, but the timeline to a routine production workflow is still likely five to ten years for most use cases.

    Genomics and population health

    Quantum and quantum inspired algorithms show early promise for problems that are awkward for classical methods: pangenome graph alignment, polygenic risk score optimisation, and clustering of high dimensional patient phenotypes. The UK has a structural advantage here because of consented, linked datasets at population scale.

    The PQC obligation for NHS trusts

    Patient records, genomic data and care plans remain sensitive for a lifetime. That puts NHS data squarely in the harvest now, decrypt later bullseye. NCSC guidance and the NHS Digital security framework both flag post quantum readiness as a near term planning item.

    • Inventory cryptographic dependencies in PAS, EPR and image archive systems.
    • Pressure clinical software vendors for a PQC roadmap aligned with NIST FIPS 203, 204 and 205.
    • Treat long lived backups and research data extracts as high priority migration targets.

    Practical next steps for a UK trust or life sciences org

    Most healthcare organisations do not need a quantum computing team. They need a small standing capability that can read vendor roadmaps, run a readiness assessment, and make sensible buy versus partner decisions over the next three years.

    Frequently asked questions

    Will quantum computers replace AI in drug discovery?

    No. The likely future is hybrid: classical AI for triage and generation, quantum for the small but valuable subset of problems where exact quantum chemistry matters.

    Is patient data at risk from quantum attacks today?

    Live decryption, no. Harvested encrypted backups and exports decrypted in the 2030s, yes. That is why PQC inventory work should begin now.

    Want a tailored view for your organisation?

    Get in touch and qubion will match you with marketplace vendors who can map your quantum exposure, opportunities and a 12 to 36 month plan.

    Find a vendor

    Keep reading

    Cryptography

    Harvest now, decrypt later: what UK CISOs need to know

    Adversaries are capturing UK encrypted traffic now to decrypt once quantum arrives. The threat model, data most at risk, and a 12-month CISO plan.

    Strategy

    Quantum risk assessment: a five step framework for UK enterprises

    A board-ready five-step framework for assessing quantum risk across cryptography, supply chain, talent and compute strategy in your UK organisation.